The following list is designed to provide up-to-date information on our on-going clinical studies. It is intended primarily to help patients, their carers and physicians to know which clinical trials are active. The company has a policy to post its clinical trials on www.clinicaltrials.gov.
DELOS - Catena® for the treatment of Duchenne Muscular Dystrophy
The Phase III study is ongoing, but not recruiting patients. For further information about the DELOS study, click here.
MELTIMI - Catena® for treatment of MELAS
The Phase II study is ongoing, but not recruiting patients. For further information about the MELTIMI study, click here.
IPPOMS - Catena® for treatment of Primary Progressive Multiple Sclerosis
This Phase II study is recruiting in the United States. For further information about the IPPOMS study, click here.